Hyogo, Japan

Michiko Taniguchi




Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michiko Taniguchi: Innovator in Oral Vaccine Development

Introduction

Michiko Taniguchi is a prominent inventor based in Hyogo, Japan. She has made significant contributions to the field of medical science, particularly in the development of oral vaccines. Her innovative work aims to combat bacterial infectious diseases, showcasing her dedication to improving public health.

Latest Patents

Taniguchi holds a patent for an oral vaccine designed to protect against bacterial infectious diseases such as typhoid fever, cholera, and dysentery. The invention features a capsule formulation that encapsulates a transformed microorganism expressing a flagellin antigen protein. This formulation is protected by an acid-resistant membrane, ensuring its efficacy in the gastrointestinal tract. The patent highlights various forms of the capsule, including seamless, soft, and hard capsule formulations.

Career Highlights

Throughout her career, Michiko Taniguchi has been associated with Morishita Jintan Co., Ltd., where she has contributed to groundbreaking research and development in vaccine technology. Her work has garnered attention for its potential to enhance vaccine delivery and effectiveness.

Collaborations

Taniguchi has collaborated with notable colleagues, including Toshiro Shirakawa and Masato Kawabata. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of vaccine research.

Conclusion

Michiko Taniguchi's contributions to oral vaccine development represent a significant advancement in medical science. Her innovative approach and dedication to combating infectious diseases highlight the importance of research in improving global health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…